by Julianne Stahl
Associates in Action articles highlight CSG Associates’ philanthropic efforts and public-private partnerships throughout the states.
Neurocrine Bioscences, a CSG Associate, is recognizing the first full week of May 2021, as Tardive Dyskinesia (TD) Awareness Week to help increase awareness and support people living with this condition. Tardive dyskinesia, or TD, is a condition of uncontrollable movements affecting the face, torso, and/or other body parts. TD may develop after a few months of taking certain medications to treat bipolar disorder, depression or schizophrenia. The condition affects approximately 600,000 people in the United States.
By declaring the first week of May as TD Awareness Week, 40 states and Washington, D.C. are helping to raise awareness around:
- The impact TD can have on a person’s physical, emotional and social well-being.
- The signs and symptoms associated with TD
- The importance of working with one’s doctor to manage the condition, including talking about available treatment options
May is also Mental Health Month, established in 1949 by the National Association for Mental Health. This is an important time to acknowledge the one in five U.S. adults living with a mental illness. The uncontrollable movements of TD may be disruptive to people’s lives due to the symptoms themselves and the impact they can have on their emotional and social wellbeing.
Research shows a gap in awareness and need for further education. Data from the RE-KINECT study, the largest real-world screening study of patients with clinically confirmed possible TD, demonstrated that 75% of the 204 participants affirmed feeling self-conscious or embarrassed about involuntary movements.
Neurocrine Biosciences is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.
For more information on TD Awareness Week, please visit: TalkAboutTD.com